Renin-angiotensin-aldosterone system inhibitors
3 papers2 findings
- 1 lab in 1 country
- 1 finding against
- Humans2
Outcomes
1Left ventricular dysfunction
no changein humans1HR 1.1
1 study
Left ventricular dysfunction
no changein humans1HR 1.1
Renin-angiotensin-aldosterone system inhibitors have no effect on left ventricular dysfunction in humans (HR 1.10, 95% CI 0.80–1.52).
“this effect was not observed in the low-risk group (HR, 1.10; 95% CI, 0.80–1.52; p for interaction = 0.028; Figure 1).”
Humansin AI-ECG low-risk group with baseline LVEF ≥ 50%median follow-up of 1,320 days
AHA Scientific Sessions 2025 abstract3 Nov 2025
Associations
1Left ventricular dysfunction
downin humans1HR 0.7
1 study
Left ventricular dysfunction
downin humans1HR 0.7
Renin-angiotensin-aldosterone system inhibitors lower the risk of left ventricular dysfunction in humans (HR 0.70, 95% CI 0.54–0.90).
“In the high-risk group, ACEi or ARB therapy was associated with a lower risk of LVEF decline compared to no treatment (HR, 0.70; 95% CI, 0.54–0.90)”
Humansin AI-ECG high-risk group with baseline LVEF ≥ 50%median follow-up of 1,320 days
AHA Scientific Sessions 2025 abstract3 Nov 2025
Latest
1 in 12 monthsAHA Scientific Sessions 2025 Abstract
Protective Effect of Renin–Angiotensin–Aldosterone System Inhibitors Guided by Artificial Intelligence–Enabled Electrocardiograms on Incident Left Ventricular Dysfunction: A Multicenter Cohort Study
Cohort study of 7,169 peopleInterventions
Diabetes/metabolism Research and Reviews
Endothelial Dysfunction and Therapeutic Advances in Chronic Kidney Disease
ReviewKidney
Scientific Reports
Predicting early mortality in hemodialysis patients: a deep learning approach using a nationwide prospective cohort in South Korea
Cohort study of 3,284 peopleBiomarkers